iBio, Inc. (IBIO)
Nasdaq: IBIO · Pharmaceutical Preparations · New York, NY · filing with the SEC since 2008
Filings
456 filings since 2017 beside 161 insider forms · Non-accelerated filer and smaller reporting company · read from EDGAR on Nov 13, 2026Due nextNon-accelerated filer and smaller reporting company
10-Q
Quarterly report for the quarter ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end.
by Feb 14, 2027
10-K
Annual report for the fiscal year ending Jun 30, 2027Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends.
by Sep 28, 2027
A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 41 days after the quarter ended. The proxy statement was last filed Sep 4, 2026.
Filings a yearinsider forms included
5094634964578468
2026 counts to Nov 13, 2026.
Officer or director change (8-K item 5.02): 6 times in the last 36 months, the newest Oct 19, 2026.Listing warning from its exchange (8-K item 3.01): 2 times in the last 36 months, the newest Aug 1, 2025.Auditor change (8-K item 4.01): 1 time in the last 36 months, the newest Feb 21, 2024.SEC letters: 14 in the last 36 months, the newest Mar 4, 2026.
Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.
FiledFormWhat it is, in plain wordsPeriodAsk
Oct 19, 2026
8-K items 5.02, 5.03, 5.07, 9.01
Officer or director change; Charter, bylaw or fiscal-year change; Shareholder vote · Current report
Oct 14, 2026
Oct 13, 2026
8-K items 7.01, 8.01, 9.01
Investor disclosure (Regulation FD); Other event · Current report
Sep 14, 2026
8-K items 7.01, 8.01, 9.01
Investor disclosure (Regulation FD); Other event · Current report
Aug 4, 2026
8-K items 5.02, 8.01, 9.01
Officer or director change; Other event · Current report
Jul 31, 2026
Jul 1, 2026
8-K items 7.01, 8.01, 9.01
Investor disclosure (Regulation FD); Other event · Current report
May 8, 2026
8-K items 5.02, 7.01, 9.01
Officer or director change; Investor disclosure (Regulation FD) · Current report
May 7, 2026
Apr 8, 2026
8-K items 7.01, 8.01, 9.01
Investor disclosure (Regulation FD); Other event · Current report
Mar 9, 2026
8-K items 7.01, 8.01, 9.01
Investor disclosure (Regulation FD); Other event · Current report
Feb 27, 2026
8-K items 1.01, 1.02, 9.01
Major agreement signed; Major agreement ended · Current report
Feb 23, 2026
40 of 456 shown
Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.